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Abstract
Background: Human papillomavirus 16 (HPV16) species group (alpha-9) of the Alphapapillomavirus genus contains HPV16,
HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. These HPVs account for 75% of invasive cervical cancers worldwide. Viral
variants of these HPVs differ in evolutionary history and pathogenicity. Moreover, a comprehensive nomenclature system
for HPV variants is lacking, limiting comparisons between studies.
Methods: DNA from cervical samples previously characterized for HPV type were obtained from multiple geographic
regions to screen for novel variants. The complete 8 kb genomes of 120 variants representing the major and minor lineages
of the HPV16-related alpha-9 HPV types were sequenced to capture maximum viral heterogeneity. Viral evolution was
characterized by constructing phylogenic trees based on complete genomes using multiple algorithms. Maximal and viral
region specific divergence was calculated by global and pairwise alignments. Variant lineages were classified and named
using an alphanumeric system; the prototype genome was assigned to the A lineage for all types.
Results: The range of genome-genome sequence heterogeneity varied from 0.6% for HPV35 to 2.2% for HPV52 and
included 1.4% for HPV31, 1.1% for HPV33, 1.7% for HPV58 and 1.1% for HPV67. Nucleotide differences of approximately
1.0% - 10.0% and 0.5%–1.0% of the complete genomes were used to define variant lineages and sublineages, respectively.
Each gene/region differs in sequence diversity, from most variable to least variable: noncoding region 1 (NCR1) /noncoding
region 2 (NCR2) .upstream regulatory region (URR). E6/E7 . E2/L2 . E1/L1.
Conclusions: These data define maximum viral genomic heterogeneity of HPV16-related alpha-9 HPV variants. The
proposed nomenclature system facilitates the comparison of variants across epidemiological studies. Sequence diversity
and phylogenies of this clinically important group of HPVs provides the basis for further studies of discrete viral evolution,
epidemiology, pathogenesis and preventative/therapeutic interventions.
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Introduction
Persistent infection of specific types of genital human
papillomaviruses (HPVs) is the central cause of cervical cancer
and its precursor, cervical intraepithelial neoplasia (CIN).
Cervical cancer is the most common gynecologic malignancy
and one of the leading causes of cancer mortality in women
worldwide [1,2]. Over 150 HPV types have been fully
characterized; approximately sixty of these are predominantly
detected in the cervical epithelia and sort to the Alphapapillomavirus
genus [3,4]. Most oncogenic or high-risk (HR) types associated
with invasive cervical cancer[5,6,7] are phylogenetically clustered
within either the Human papillomavirus 16 (alpha-9) or Human
papillomavirus 18 (alpha-7) species groups [8], and account for
,75% and ,15% of all cervical cancers worldwide, respectively
[6,7].
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20183Human papillomavirus nomenclature is established by the
International Committee on Taxonomy of Viruses (ICTV) based
on recommendations from the Study Group of Papillomavirus
[3,4,9]. The ICTV uses strict definitions for genera and species,
but does not set standards below the species level [10].
Papillomavirus researchers evolved a ‘‘community’’ nomenclature
that has been widely embraced and extremely useful in
epidemiological studies [3,4]. A distinct papillomavirus (PV)
‘‘type’’ is established when the nucleotide sequence of the L1
gene of a cloned virus differs from that of any other characterized
types by at least 10% [3,4]. To date, the ICTV has not recognized
the ‘‘type’’ terminology, nor the naming of species group by
number [9]. In addition, the lexicon of lower taxonomic levels,
such as serotypes, strains, variants are not under the aegis of the
ICTV. Within the PV research community, isolates of the same
HPV type are referred to as variants or subtypes when the
nucleotide sequences of their L1 genes differ by less than 10%.
Except for HPV16, HPV18, HPV45 and HPV97 there has not
been a systematic study of HPV genome variation, nor a logical
and standard classification system of variant lineages [11,12].
Given that the HPV alpha-9 group plays such an important role in
human cancer and variant lineages have different pathologic
potentials, a comprehensive evolutionary study and classification
system is needed. For instance, the upstream regulatory region
(URR) sequences have most often been used to describe intratypic
diversity and variant lineages. However, it would be valuable to
relate changes throughout the genome with specific variant
lineages.
HPV16 and HPV18 partial and complete viral sequences form
evolutionary trees with the bifurcation driven by variants with high
prevalences in cohorts from different regions of the world [13,14].
This evolutionary divergence is reflected in the phylogeny of these
strains and is reminiscent of the migration patterns of Homo sapiens
and suggests that HPV variant lineages may have co-diversified
with human populations as they exponentially expanded across the
planet. The intratypic evolutionary studies of HPV16 and HPV18
variants were initially inferred from the partial URR and E6
sequences, and have been recently expanded to include the
complete genomes [11,12,15]. Subsequent studies have investi-
gated the genetic variation of other HPV types. Comparisons of
isolates of HPV6 and 11 [16,17], HPV5 and 8 [18,19], HPV2, 27
and 57 [20], HPV44 and 68 [21], HPV53, 56 and 66 [22],
HPV31, 33, 35, 52 and 58 [23,24,25,26,27,28], and other rare
HPV types [29] have confirmed that each type demonstrates
various degrees of genomic diversity, although the association of
variant lineages and geographic origins remains a bit murky,
probably due to sampling biases. However, most previous studies
have sampled small, partial regions of the viral genome generally
limited to the E6 and L1 open reading frames (ORFs) and the
URR region. A systematic study of HPV variants and the
evolutionary dynamics has not been established for the HPV16-
related alpha-9 types.
Despite phylogenetic relatedness, HPV variants can differ in
pathogenicity. There is a three-fold or greater risk of cervical
cancer for Asian-American (AA) or African (Af) HPV16 variants
compared to European (E) variants; and, non-European variants
of HPV18 may be more common in cancer tissues and high-
grade cervical lesions [30,31,32]. HPV16 and HPV18 variants
confer different risks of viral persistence and/or progression to
precancer/cancer. Nevertheless, there is almost no data on the
natural history of other high-risk (HR) HPV variants. For
example, it is not known whether HPV31, a less-studied
oncogenic type, represents a homogeneous or heterogeneous set
of variants with similarities or differences in viral persistence and/
or oncogenicity. Although an HPV33 variant (C7732G) and an
HPV58 variant (C632T and G760A) have been reported to be
associated with a higher risk of cervical cancer [33,34], the lack of
a coherent classification and nomenclature system for HPV
variant lineages does not facilitate comparison with other studies
that measure variability in a different region of the viral genome
for classification. Moreover, specific variants occur on lineages
fixed by stochastic processes that likely include some type of, as
yet unmeasured, natural selection for increased viral fitness
[11,35].
In this report, the complete 8 kb genomes of 120 variants
representing major lineages and sublineages of HPV16-related
alpha-9 types (HPV31, 33, 35, 52, 58 and 67) were selected and
sequenced to capture maximum viral heterogeneity. Variations
across the genomes were identified and the evolutionary
phylogeny and nomenclature of the alpha-9 variant lineages are
described and will enable future studies of their discrete evolution,
epidemiology, pathogenicity and vaccine response differences.
Table 1. Summary of HPV isolates and sequenced complete genomes.
HPV type
Total no.
sampled
a
Total no.
sequenced
b
Genome size
(nucleotides)
c
Variable nucleotide
positions
d
Total potential
amino acid positions
e
Variable amino
acid positions
f
31 316 22 7967 (7878, 7945) 299 (3.8%) 2302 109 (4.7%)
33 179 20 7912 (7830, 7912) 186 (2.4%) 2284 69 (3.0%)
35 214 23 7908 (7876, 7908) 140 (1.8%) 2306 46 (2.0%)
52 481 22 7993 (7933, 7974) 354 (4.4%) 2326 105 (4.5%)
58 447 26 7837 (7814, 7836) 400 (5.1%) 2326 148 (6.4%)
67 32 7 7825 (7801, 7819) 135 (1.7%) 2321 45 (1.9%)
aNumber of HPV isolates characterized by sequencing the URR 6 E6 region;
bNumber of isolate genomes sequenced;
cNumber of nucleotide sequences within the genome based on one genome size for each HPV type calculated from the global sequence alignments (see Materials and
Methods). Minimum and maximum lengths of sequenced genomes for each type are shown and represent the presence of insertion and deletions (indels);
dTotal number and percentage of variable nucleotide positions based on one genome size for each HPV type as described above. Nucleotide variations include single
nucleotide polymorphisms (SNPs) and indels, which are considered equivalent to one variation per indel independent of indel size;
eMaximum number of encoded amino acids (not including overlapping ORFs) based on one genome size for each type as described above. Cumulative number of
amino acids are taken from 7 ORFs (E6, E7, E1, E2, E5, L2 and L1), E4 is not counted separately nor are other overlapping ORFs;
fTotal number and percentage of variable amino acids based on the total number of amino acid positions derived from the established genome size for each HPV type.
doi:10.1371/journal.pone.0020183.t001
HPV16-Related Alphapapillomavirus Variant Genomes
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e20183Materials and Methods
Clinical specimens, identification of novel HPV variants
and whole genome sequencing
DNA from cervicovaginal samples already determined to have
HPV16-related alpha-9 types (HPV31, 33, 35, 52, 58 and 67) by
previous testing were available from women participating in
epidemiological studies worldwide, including - Costa Rica [36],
Taiwan [37], Thailand [38,39], Rwanda [40], Burkina Faso [41]
and Zambia [42]. The methods for sample collection and HPV
typing are provided in the references from each study. The
number of samples analyzed for each type is shown in Table 1.
The HPV genomes within the DNA samples were classified by
sequencing the URR and/or E6 regions from PCR products as
described [43]. Briefly, we used type-specific primers to amplify a
partial fragment of the URR region and/or the E6 ORF using a
one-tube nested PCR method [44]. The E6 ORF was evaluated
only for those specimens that did not yield data for the URR
region. The PCR product sizes were confirmed by gel electro-
phoresis, purified using the QuickStep 2 PCR Purification kit
(Edge BioSystems, Gaithersburg, MD) or QIAquick Gel Extrac-
tion kit (Qiagen, Valencia, CA) and submitted for sequencing of
both strands at the Einstein Genomics Facility. The sequences for
each type under study were separately aligned and preliminary
phylogenetic trees were used to identify samples that likely
contained diverse viral genomes (data not shown). Based on this
analysis, we selected type-specific viral isolates for complete
genome sequencing that (1) represented different variant clades
or (2) had 2 or more isolates that contained at least 2 unique
sequence variations (e.g., single nucleotide polymorphisms (SNPs))
not present in other isolates within the URR/E6 regions.
The subset of viral genomes sequenced captured the maximum
diversity noted in sequencing the URR/E6 regions. The number of
genomes selected for sequencing for each type was based on
identificationofdivergentisolatesanddifferedforeachtype(table1).
The complete 8 kb genomes from clinical samples were amplified in
2 to 3 overlapping fragments using type-specific primer sets
(available from authors) based on the prototype sequence of each
Figure 1. Alpha-9 phylogenetic tree showing representative types and variant lineages. A phylogenetic tree was constructed using the
MrBayes (v3.1.2) program [48] inferred from the global alignment of complete circular genome nucleotide sequences linearized at the first ATG of the
E1 ORF. To root the tree, HPV34 and HPV73 prototype sequences (NCBI accession numbers NC_001587 and NC_006165, respectively) were set as the
outgroup and are represented by grey broken lines. The Bayesian credibility values less than 100 were indicated on or near the branch nodes. The
shaded areas represent groupings of lineages and sublineages of HPV16, HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. The length of broken and
solid lines represent distance between clades, although the number of changes is different for these two lines, the scale is indicated in the upper left
corner of the figure.
doi:10.1371/journal.pone.0020183.g001
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DNApolymerase (Applied Biosystems, Carlsbad, CA)and Platinum
Taq DNA Polymerase (Invitrogen, Carlsbad, CA) were utilized as
previously described [11,12,45]. PCR products of anticipated size,
as determined by gel analyses, were either directly sequenced or
cloned into pGEM-T easy (Promega, Madison, WI) or TOPO TA
pCR2.1 vectors (Invitrogen, Carlsbad, CA) and then sequenced.
Comparison of repeat sequencing of PCR products from the same
isolatesresulted ina difference oflessthan one change per8,000 bp;
whereas, comparison of the cloned genomes gave a difference of
approximately one difference per 5,000 bp. For discrepancies
betweensequences, weused the sequence ofthe PCRproduct asthe
valid sequence. HPV complete genome sequences were submitted
to GenBank; the accession numbers are listed in Table S1.
Evolutionary analyses and phylogenetic tree construction
The nucleotide sequences of the complete circular genomes
were linearized at the first ATG of the E1 ORF and globally
aligned using the program MAFFT v6.846 [46]. Based on the
concept of a single ancestor for each type, a unique genome size is
assigned to each HPV type based on the global alignment and the
variation in genome size of the isolated variants is ascribed to
insertions and deletions (indels). Each indel was counted as one
event. The assignment of position numbers for each nucleotide is
based on the nucleotide numbering of the prototype reference
sequence.
MrBayes v3.1.2 [47,48] with 10,000,000 cycles for the Markov
chain Monte Carlo (MCMC) algorithm was used to generate
phylogenetic trees from the aligned complete genome nucleotide
sequences. For Bayesian tree construction, the computer program
ModelTest v3.7 [49] was used to identify the best evolutionary
model; the identified gamma model was set for among-site rate
variation that allowed substitution rates of different sites to vary.
Maximum parsimony (MP) and neighbor joining (NJ) trees were
calculated by a heuristic search in PAUP* v4.0b10 [50]. For
maximum parsimony analyses, nucleotide sequences were reduced
to phylogenetically informative sites. Data were bootstrap
resampled 1,000 times. Trees are shown in Figures 1 – 7.
Figure 2. HPV31variant tree topologies andpairwise comparisons of individual complete genomes. Bayesian trees were inferred from
global alignment of complete genome nucleotide sequences (the other HPV16-related HPV reference prototypes were set as the outgroup). Numbers
on or near branches indicate support indices in the following order: Bayesian credibility value using MrBayes v3.1.2 [48], maximum parsimony (MP)
bootstrap percentage and neighbor joining (NJ) bootstrap percentage using PAUP* v4.0b10 [50]. An asterisk (*) indicates 100% agreement between
methods. ‘‘NA’’ reflects disagreement between a method and the reference Bayesian tree at a given node. Thus, one tree is shown, but three different
methods of tree construction were used to estimate the support of the provided tree, as explained above. Distinct variant lineages (i.e., termed A, B,
and C) are classified according to the topology and nucleotide sequence differences from .1% to ,10%. The percent nucleotide sequence
differences were calculated for each isolate compared to all other isolates of the same type based on the complete genome nucleotide sequences
and are shown in the panel to the right of each phylogeny. Values for each comparison of a given isolate are connected by lines and the comparison
to self is indicated by the 0% difference point. Symbols and lines used are different for each distinct variant lineage to facilitate visual comparisons.
For example, percentage differences of variant lineage A are indicated by X’s and connected by broken lines; values for isolates of variant lineage B
are indicated by closed triangles and connected by solid lines; and, difference values of lineage C isolates are indicated by open circles and connected
by a dotted line.
doi:10.1371/journal.pone.0020183.g002
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es of the ‘‘early genes’’ (E6, E7, E1, E2 and E5) and ‘‘late genes’’
(L2 and L1), in order to assess changes in tree topology [51]. The
amino acids of each ORF were aligned using MUSCLE v3.7 [52]
within the Seaview v4.1 program [53]; the nucleotide sequences of
each codon region were then aligned using the corresponding
aligned amino acid sequences.
SNPs within the HPV genomes and lineage-specific SNPs were
determined from alignments of type specific variant genomes using
MEGA5 [54] and MacClade v4.08 [55], respectively and are
displayed in Figure 8. Positions of SNPs and indels are based on
the prototype reference sequence. Mean nucleotide differences
and standard errors between and within type-specific lineages and
sublineages were calculated from the global sequence alignment of
each type using MEGA5 bootstrapped 1,000 times [54]. The
rarefaction curves (shown in Figure 9) for each type were
generated by EstimateS v8.2 [56].
Results
Human papillomavirus isolates of known types were obtained
from previously characterized cervicovaginal exfoliated cells from
a variety of studies performed in different geographic locations.
We reasoned that this large set of clinical materials would capture
a major portion of the genomic diversity of the HPV16-related
HPV types. The core set of clinical samples originated from a large
(10,000 women) population-based study of HPV and cervix
neoplasia in Costa Rica [43], and was supplemented with clinical
materials obtained from 3 regions in Africa - Burkina Faso [41],
Rwanda [40], and Zambia [42]; and two locations in Asia –
Thailand [38,39] and Taiwan [37]. Complete genome sequences
that originated in China (available from GenBank) were also
included in this analysis, as were the reference sequences for
HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67.
HPV variant lineage classification and nomenclature
The taxonomic grouping and the naming of variant lineages
and sublineages were based on the distributions of pairwise
comparisons of variant genomes for each HPV type (Figure S1). A
similar strategy was previously used for classification of HPV types,
species and genera [3]. The distribution of percent differences
between variants revealed a bimodal pattern (Figure S1A). This
bimodal distribution of individual comparisons indicates that there
are variants that are closer related to some variants but not others,
thus supporting the grouping of major lineages for each type.
Examination of phylogenies for each type (see data presented
below) combined with an approximate cut off of 1.0% difference
between genomes was used to define major variant lineages. Each
major lineage was named using an alphanumeric, with the ‘‘A’’
clade always containing the reference genome for each type. The
robustness of this system was examined by viewing the distribution
of pairwise comparisons within each variant lineage (i.e., intra-
lineage) or between variant lineages for each HPV type (i.e., inter-
lineage) (Figure S1B). The overlap between these distributions
(0.7%–0.9%) is the reason a fixed value cannot be used to
Figure 3. HPV33 variant tree topologies and pairwise comparisons of individual complete genomes. The phylogenetic tree was
constructed as described in Figure 2. Distinct variant lineages (i.e., termed A and B) are classified according to the topology and nucleotide sequence
differences from .1% to ,10%. Distinct sublineages (i.e., termed A1 and A2) were also inferred from the tree topology and nucleotide sequence
differences in the .0.5% to ,1% range. The percent nucleotide sequence differences were calculated and are shown in the panel to the right of each
phylogeny as described in Figure 2.
doi:10.1371/journal.pone.0020183.g003
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the caveat that no classification system can exactly classify the
process of millions of years of evolution. A similar pattern was seen
for the distribution between and within the genome comparisons
of sublineages for each HPV type (Figure S1C). Differences
between genomes in the 0.5%–1% range were designated as
sublineages (e.g., A1, A2, etc.).
Genomic diversity of HPV31 variants
Three hundred and sixteen HPV31 isolates had the URR and/
or E6 regions sequenced (Table 1). These sequences clustered into
three main clades from which 22 samples, selected for maximum
diversity, were used for complete genome analyses. A total of 299 /
7967 (3.8%) nucleotide positions showed variations compared to
the prototype sequence [57] (variable nucleotide sequence
positions for each sample are shown in Figure S2A). There were
109 / 2302 (4.7%) encoded variable amino acids (Table 2). The
maximum nucleotide pairwise difference between the most
dissimilar isolates was 1.4% (Table 2). The most variable region
was the noncoding region 2 (NCR2) between E2 and E5 ORFs
with 10.2% overall nucleotide diversity (Table 2). One isolate,
QV14117, has a 3 bp deletion (ACA) at nt. 1315–1317, resulting
in the loss of a threonine at aa 152 within the E1 ORF (Figure
S2A).
Phylogenetic trees generated from the complete genome
nucleotide sequences clustered HPV31 variants into three distinct
lineages designated A, B and C (Figures 1 and 2). As previously
described, the HPV31 prototype (HPV31.REF) was assigned to
the A lineage (Figure 2). Lineage C was relatively distant to
lineages A and B with mean differences of 1.2%60.11% and
1.2%60.12%, respectively (Table S2). Phylogenetic trees inferred
from the early vs. late regions of the genome showed similar
topologies (Figures S3A and S3B). Within the HPV31 genomes, 74
variable nucleotide positions are lineage specific (Figure 8). These
variations represent ancestral changes specific to each of the 3
different lineages that have evolved from their common ancestor.
Genomic diversity of HPV33 variants
Isolates from 179 samples containing HPV33 were classified by
sequencing the URR/E6 region and constructing phylogenetic
trees (Table 1). Twenty independent complete genomes were
sequenced that captured the maximum inter-lineage and intra-
lineage heterogeneity based on the URR/E6 region variability.
The overall nucleotide and amino acid diversity of the complete
genomes were 2.4% (186 sites among 7912 nt) and 3.0% (69 sites
among 2284 aa), respectively (Table 2 and Figure S2B). HPV33
isolates QV06895 and QV23819 were the most distantly related
genomes with a nucleotide sequence difference of 1.1%; this
distance represented the maximum inter-lineage diversity of
HPV33 variants (Table S2).
As shown in Figure 3, the topology of the tree constructed with
HPV33 variants revealed two distinct lineages, termed A and B.
Lineage A was relatively variable and was further divided into two
sublineages A1 and A2, that were 0.6%60.07% dissimilar. These
Figure 4. HPV35 variant tree topologies and pairwise comparisons of individual complete genomes. The phylogenetic tree was
constructed as described in Figure 2. There were no distinct variant lineages however, sublineages (i.e., termed A1 and A2) were inferred from the
tree topology and nucleotide sequence differences in the .0.5% to ,1% range. The percent nucleotide sequence differences were calculated and
are shown in the panel to the right of each phylogeny as described in Figure 2.
doi:10.1371/journal.pone.0020183.g004
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difference of 0.9%60.09% nucleotides (Figure S2B, Table S2).
Lineage and sublineage specific nucleotide variations were
determined across the complete genome (11 changes for the
sublineage A1, 12 for A2, and 38 for B) (Figures 8 and S2B).
Insertion and/or deletion (indel) events were detected within the
NCR2 and URR regions. Sublineage A1 variants had a long
insertion of 79 bp (nt. 7583–7661) within the URR region (Figure
S2B).
Genomic diversity of HPV35 variants
We sequenced the URR/E6 region of 214 HPV35 samples and
selected 23 isolates representing each unique variation pattern for
complete genome analyses (Table 1). Nevertheless, all variants
were highly conserved; the maximum pairwise difference was
0.6% (QV19086 vs QV29782) (Table 2 and Figure S2C), and the
overall nucleotide diversity was 1.8% (140/7908) (Table 2). In
total, 46 / 2306 (2.0%) variable aa positions were detected
(Table 2). It should be noted that the isolates analyzed in this study
covered the majority of previously reported variations and may
represent the maximum genomic heterogeneity of HPV35 variants
(Figure 9) [23,24,26].
Although HPV35 variants clustered into two clades (Figure 4),
the 0.5%60.06% inter-clade mean difference did not support
classification into separate variant lineages (Table S2). Thus,
HPV35 variants were divided into two sublineages, A1 and A2.
Fourteen sublineage specific nucleotide variations were identified,
7 located within the L2 ORF (Figure 8).
Genomic diversity of HPV52 variants
Amplification and sequencing the URR/E6 region of 481
samples containing HPV52 resulted in the selection of 22 isolates
for complete genome analyses (Table 1). In total, 354 nucleotide
sites were variable across the 7993 bp HPV52 genome (4.4%)
(Table 1). Of the 2326 encoded amino acids, 105 (4.5%) were
variable (Table 3). The maximum nucleotide diversity was 2.2%
observed between isolates QV00615 and QV07294. Other
features of HPV52 genomes included- the NCR2 and URR
regions contained indels, and the L1 ORF had a 3-bp insertion
(GGG) between nt. 6191 and 6192 within isolates QV12377 and
QV02575 resulting in an insertion of glycine between aa. 209 and
210 (Figure S2D).
Phylogenetic trees inferred from the complete genome nucle-
otide sequences separated HPV52 variants into four distinct
lineages A, B, C and D (Figure 5). The lineages A, B and C form
one clade, and are 0.8%–1.1% different among themselves, and
distantly separated from lineage D (mean differences of 1.8%–
2.0%) (Table S2). The deep separation between lineages C and D
(2.0%60.14% different) is similar to that observed between
HPV16 variant lineages E (As) and AA (1.9%60.15% different)
[11] and HPV18 variant lineages Af and non-Af (2.0%60.16%
different) [12].
Figure 5. HPV52 variant tree topologies and pairwise comparisons of individual complete genomes. The phylogenetic tree was
constructed as described in Figure 2. Distinct variant lineages (i.e., termed A, B, C and D) are classified according to the topology and nucleotide
sequence differences from .1% to ,10%. Distinct sublineages (i.e., termed B1, B2, C1 and C2) were also inferred from the tree topology and
nucleotide sequence differences in the .0.5% to ,1% range. The percent nucleotide sequence differences were calculated and are shown in the
panel to the right of each phylogeny as described in Figure 2.
doi:10.1371/journal.pone.0020183.g005
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into sublineages, B1 and B2 (0.6%60.08% different), and C1 and
C2 (0.6%60.07% different) (Figure 5 and Table S2). There were
97 nucleotide changes specific for lineage D, while lineages A, B
and C have 15, 8, and 18 unique distinguishing nucleotide
variations, respectively (Figures 8 and S2D). There were multiple
indels in the NCR2 and URR regions and an insertion of GGG
encoding glycine within the L1 ORF of isolates Qv12377 and
Qv2575 (Figure S2D). The noncoding regions (NCR1, NCR2 and
URR) were most variable in overall nucleotide diversity, followed
by E5/E4/E7, E6/L1, and L2/E1 (Table 3).
Genomic diversity of HPV58 variants
The URR/E6 partial sequences clustered 447 HPV58 variants
into four major clades; 26 isolates capturing the maximum viral
genomic heterogeneity were amplified and sequenced (Table 1). In
addition, 10 HPV58 variant complete genomes from China were
available from GenBank (listed in Table S1) and were included in
the complete genome analyses. In total, 400 variable nucleotide
positions were identified within the 7837 bp HPV58 genome
(5.1%) (Table 3). There were 148/2328 variable amino acids
(6.4%) (Table 3, Figure S2E). There was a 1.7% maximum
pairwise nucleotide difference between isolates QV03554 and
RW063. Three isolates, QV03841, QV03858, QV04732 had a 3-
bp deletion within the E2/E4 ORF (nt. 3527 – 3529 of E2 and nt.
3525 – 3527 of E4), resulting in the loss of a glycine (aa. 259 of E2)
and a glutamic acid (aa. 67 of E4) (Figure S2E).
Phylogenetic topology and percent nucleotide differences
between clades classified HPV58 variants into four lineages (A,
B, C and D) that are further parsed into seven sublineages (A1/
A2/A3, B1/B2 and D1/D2) (Figure 6). The inter-lineage mean
difference of HPV58 variants ranged from 0.9%–1.4%, and the
inter-sublineage differences were 0.5%–0.7% (e.g., A1 vs A2)
(Table S2). Although sublineages B1 and B2 did not cluster
together in the complete genome tree (Figure 6), both were
more closely related to each other (0.7%60.07% different) than
to other lineages/sublineages (.1.0% mean differences) (Table
S2). One hundred and forty nucleotide changes are lineage-
and/or sublineage- specific (Figures 8 and S2E). All 447 HPV58
isolates from our laboratory had a C307T change within E6;
whereas, except for TJ18_58, all HPV58 isolates from Chinese
patients had a cytosine (C) at nt. 307 identical to the prototype
Figure 6. HPV58 variant tree topologies and pairwise comparisons of individual complete genomes. The phylogenetic tree was
constructed as described in Figure 2. Distinct variant lineages (i.e., termed A, B, C and D) are classified according to the topology and nucleotide
sequence differences from .1% to ,10%. Distinct sublineages (i.e., termed A1, A2, A3, B1, B2, D1 and D2) were also inferred from the tree topology
and nucleotide sequence differences in the .0.5% to ,1% range. The percent nucleotide sequence differences were calculated and are shown in the
panel to the right of each phylogeny as described in Figure 2.
doi:10.1371/journal.pone.0020183.g006
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(Figure 6).
Genomic diversity of HPV67 variants
HPV67 has a low prevalence throughout the world making
accurate assessment of its variability and oncogenicity difficult.
T h e r ew e r eat o t a lo f3 2c e r v i c o vaginal samples containing
amplifiable HPV67, of which 7 complete genomes represent-
ing different variant patterns were characterized (Table 1).
There were 135 nucleotide changes across the 7825 bp
genome (1.7%), and 45 / 2321 amino acid positions were
variable (1.9%) (Table 3). The nucleotide sequence difference
between isolates QV22701 and QV24827 (1.1% difference)
represents the maximum inter-lineage diversity (Table 3 and
Figure S2F).
The eight HPV67 variant genomes formed two distinct lineages,
termed A and B, that were 1.0% different from each other
(Figure 7 and Table S2). Lineage A was further subdivided into
sublineages A1 and A2. The HPV67 prototype differed from all
other variants by .0.3% based on pairwise comparisons. There
were 16 nucleotide changes conserved among the 7 newly
sequenced HPV67 isolates that were different than the prototype
genome; it is unknown whether these polymorphisms are natural
variations or errors in the original prototype sequence. Indel
events were detected within the E2/E4, NCR2 and URR regions
(Figure S2F).
HPV16-related alpha-9 HPV genomic diversity
To estimate the coverage of type specific SNP variation within
the sample cohorts and genomes analyzed, rarefaction curves of
the single-nucleotide polymorphisms (SNPs) were plotted
(Figure 9). Based on the analysis of conserved SNP sites (i.e.,
SNPs detected in $2 samples), the plot for the combined genomes
for each type suggests that sampling of genomes within the
targeted populations may increase the repertoire of genomic
variability. However, it is unlikely to reveal novel variant lineages,
since the curves flatten out with increasing numbers of sequenced
genomes. The pairwise inter-lineage mean differences revealed
maximum genomic diversity of HPV52 and HPV58 isolates,
followed by HPV31, HPV33 and HPV67 variant genomes (Table
S2). HPV35 isolate genomes were not highly variable and only a
single lineage was observed.
When each ORF/region was compared, the noncoding
regions (NCR1, NCR2 and URR) most often showed the
largest variability, followed by the E5 and E4/E2 overlap ORFs
(Tables 2 and 3). The diversity of the E6, E7, E1, E2 (taken in its
entirety), L2 and L1 ORFs varied by type; nevertheless, the L1
ORF was not significantly more conserved in terms of the
overall nucleotide diversity compared to the other ORFs
(Tables 2 and 3).
Comparison of early and late gene phylogenies
The topology of phylogenetic trees constructed from different
genes or regions of genomes can indicate differences in
evolutionary history. We previously demonstrated that phyloge-
netic incongruence exists between trees inferred for late and early
regions of the Alphapapillomaviruses [11,51]. To evaluate whether
similar evolutionary patterns could be identified in the HPV16-
related viral genomes, we compared trees created with the early
region ORFs (i.e., E1, E2, E5, E6 and E7) to that of the late
ORFs (i.e., L1 and L2) (Figure S3, panels A and B). At the type
level, HPV16, HPV31 and HPV35 isolates formed a consistent
clade with HPV31 and HPV35 sharing a most recent common
ancestor (MRCA), as did the HPV33 and HPV58 isolates. The
position of HPV52 and HPV67 isolates varied slightly; only in the
tree using the L1/L2 did HPV52 and HPV67 isolates show
evidence of having shared a MRCA (Figure S3, panels A and B).
Comparison of trees for the early and late regions indicated some
minor changes of the topology of variant lineages, as shown in
Figure S3.
Figure 7. HPV67 variant tree topologies and pairwise comparisons of individual complete genomes. The phylogenetic tree was
constructed as described in Figure 2. Distinct variant lineages (i.e., termed A and B) are classified according to the topology and nucleotide sequence
differences from .1% to ,10%. Distinct sublineages (i.e., termed A1 and A2) were also inferred from the tree topology and nucleotide sequence
differences in the .0.5% to ,1% range. The percent nucleotide sequence differences were calculated and are shown in the panel to the right of each
phylogeny as described in Figure 2.
doi:10.1371/journal.pone.0020183.g007
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In this work, over 12,000 cervicovaginal samples from women in
the Americas (Costa Rica), Africa (Rwanda, Zambia, and Burkina
Faso) and Asia (China, Taiwan, and Indonesia) were tested for HPV
and 120 genomes from nearly 2,000 HPV16-related alpha-9 HPV
isolates (HPV31, 33, 35, 52, 58 and 67) had their complete genomes
sequenced. These HPV isolates were selected based on the analysis of
the URR/E6 regions to identify samples representing or forming
major variant lineages and also having the most diverse URR/E6
regions for each type [23,24,25,26,27,28]. Based on the analyses of
these genomes, there are two aspects of this study that deserve further
consideration. First, the descriptive aspect of the HPV16-related
alpha-9 type variants provide a framework to establish a nomencla-
tureforvariantlineages.Second,anemergingpictureoftheevolution
of this highly pathogenic clade (see Figure 1) of HPVs is discussed.
Isolates of the same HPV type were originally considered as
‘‘variants’’ when their L1 genes contained 1 to 2% nucleotide
sequence differences [4]; however, the L1 ORF does not contain
the optimal sequence information for distinguishing closely related
HPV variants. As part of the ICTV Papillomavirus Study Group,
we were recently assigned the task of developing a classification
system for HPV variants [3]. In contrast to the genera, species and
type definitions that are based on the L1 ORF nucleotide
sequence, we set the criteria for classification and nomenclature
of variant lineages and sublineages using the complete genome,
since the recently evolved variant genomes have changes that are
not always evenly distributed throughout the genome (see
Figure 8). To define distinct variant lineages, we used a nucleotide
sequence difference of approximately 1.0% between two or more
variants of the same type. This value was derived from empiric
data on the distribution of differences between genomes of the
same type (see Figure S1). Similarly, differences across the genome
of 0.5%–1.0% were used to identify sublineages. Each variant
lineage was classified and named with an alphanumeric value (see
Figure 1 for summary). The prototype sequence (i.e., the cloned
genome designated as the original type) is always designated
variant lineage A and/or sublineage A1 [12].
Variants of HPV31, 33, 52, 58 and 67, similar to HPV16 and
HPV18, form at least two deeply separated clades suggesting
codivergence of host and virus as different lineages diversified from
their most recent common ancestor (MRCA) [11,12]. HPV35
variants are highly conserved and did not meet criteria for
classification into more than one lineage. This probably represents
a recent divergence from the MRCA of the HPV31, HPV35 and
HPV16 clade. Alternatively, another variant lineage of HPV35
might exist in an isolated and/or unsampled population or could
have disappeared by genetic isolation and/or host demise.
Although HPV16 and HPV18 variants are associated with
specific geographic locations, the geographic distribution and
ethnic association of HPV31, 33, 35, 52, 58 and 67 variant
lineages are not well established. We believe a nomenclature based
on alphanumerics is preferable to one based on geographic names,
since it eliminates the problem of naming a lineage found in
multiple geographic areas.
A number of investigators have used the strategy of PCR
amplifying and sequencing one or a few informative segments to
classify isolates into different variant lineages or groups. For
example, HPV58 variants containing E7 SNPs- C632T and
G760A (aa 63G) that have been reported to be associated with
higher cervical cancer risk [34] can be classified into HPV58
sublineage A3 (Figure S2E). The C7732G SNP in HPV33
variants, which results in the loss of a putative binding site for
the cellular upstream stimulatory factor has also been associated
with high-grade squamous intraepithelial lesions (HSILs) [33].
HPV33 C7732G is a lineage specific SNP within the URR region
and represents HPV33 variant lineage A2 (Figure S2B). The URR
region contains many cis-acting regulatory sequences; variations
within these motifs may alter viral transcription and replication.
Alternatively, these changes may be markers of other linked
nucleotide changes within a lineage. A few studies have reported
that alpha-9 HPV variants differ in risk of persistence; for some
HPV genotypes, variant lineages or sublineages (e.g., HPV35 A1)
differ in their risk of CIN3+ [26,43]. Knowledge of the complete
genome sequences and phylogenetic structure will facilitate
understanding the clinical role sequence variations play in
genotype-phenotype associations. An important point of the
current analysis is showing that individual or groups of SNPs
need to be interpreted in light of the high correlation of sets of
SNPs within each lineage (Figure 8). We have previously termed
the stochastic process of papillomavirus genome accumulated
mutations, ‘‘lineage fixation’’ [11]. This has important practical
considerations in that investigators sequencing or analyzing
different regions of the genome will now be able to classify the
lineages of these variants for genotype-phenotype studies based on
Figure 9. Single-nucleotide polymorphism (SNP) rarefaction
curves. The program EstimateS v8.2.0 for Mac OS (downloaded from:
http://viceroy.eeb.uconn.edu/EstimateS) was used to illustrate the
curves. The Y-axis represents the total number of parsim-informative
single nucleotide polymorphisms (SNPs) observed in at least 2 genomes
of a specific type. Insertion and deletions are counted as one event
equal to a single SNP. The X-axis shows the number of sequenced
isolates. The curve generated for variants of each HPV type are
displayed by different lines as indicated by the key to the right of the
curves. For reference, the number of variable nucleotide positions for
HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67 genomes are 3.8%,
2.4%, 1.8%, 4.4%, 5.1% and 1.7%, respectively (see Table 1).
doi:10.1371/journal.pone.0020183.g009
Figure 8. Diagnostic lineage-specific single nucleotide polymorphisms (SNPs) and their position in the genome. Lineage-specific SNPs
were determined from alignments of type specific variants using the program MacClade v4.08 [55]. The position of variants across HPV lineage(s) and
sublineage(s) are displayed to the right of the name of the clade from which the data was abstracted, as depicted in the phylogenetic trees in
Figures 2–7. The viral genome sequence differences for each sequenced isolate are displayed in Figure S2. Regions of the genome are displayed
below the x-axis for reference. The graphic output was generated using Microsoft Excel.
doi:10.1371/journal.pone.0020183.g008
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Genome region
and ORF
Maximum nuc.
pairwise difference
Number of nucleotide
sequences
a
Number of variable
nuc. positions
b Number of
amino acids
c
Number of variable
aa positions
d
n% n %
HPV31 (n=23)
E6 2.0% 450 18 4.0% 149 9 6.0%
E7 2.4% 297 15 5.1% 98 10 10.2%
E1 1.1% 1890 48 2.5% 629 22 3.5%
E2 0.9% 1119 31 2.8% 372 17 4.6%
E4 1.6% 309 10 3.2% 102 8 7.8%
NCR1
E5 3.1% 255 13 5.1% 84 8 9.5%
NCR2 6.6% 118 12 10.2%
L2 1.5% 1401 50 3.6% 466 24 5.2%
L1 1.4% 1515 55 3.6% 504 19 3.8%
URR 3.2% 953 55 5.8%
CG
e 1.4% 7967 299 3.8% 2302 109 4.7%
HPV33 (n=21)
E6 2.2% 450 13 2.9% 149 8 5.4%
E7 2.0% 294 7 2.4% 97 4 4.1%
E1 0.8% 1935 31 1.6% 644 15 2.3%
E2 1.3% 1062 23 2.2% 353 17 4.8%
E4 2.4% 252 6 2.4% 83 4 4.8%
NCR1 2.3% 43 1 2.3%
E5 0.9% 228 4 1.8% 75 3 4.0%
NCR2 2.3% 131 3 2.3%
L2 1.1% 1404 26 1.9% 467 12 2.6%
L1 1.2% 1500 31 2.1% 499 10 2.0%
URR 2.6% 924 48 5.2%
CG
e 1.1% 7912 186 2.4% 2284 69 3.0%
HPV35 (n=24)
E6 1.6% 450 13 2.9% 149 5 3.4%
E7 1.0% 300 3 1.0% 99 2 2.0%
E1 0.3% 1914 14 0.7% 637 9 1.4%
E2 0.9% 1104 18 1.6% 367 15 4.1%
E4 1.4% 291 6 2.1% 96 2 2.1%
NCR1
E5 0.8% 252 4 1.6% 83 2 2.4%
NCR2 3.5% 145 5 3.4%
L2 0.9% 1410 23 1.6% 469 9 1.9%
L1 0.7% 1509 24 1.6% 502 4 0.8%
URR 1.6% 879 36 4.1%
CG
e 0.6% 7908 140 1.8% 2306 46 2.0%
aThe number of nucleotides within each ORF and region of the genome based on one genome size for each HPV type calculated from the global sequence alignments.
Range of values and location in the papillomavirus genome are shown in Figure S4;
bTotal number and percentage of positions based on one genome size for each HPV type calculated from the global sequence alignments. Nucleotide variations include
SNPs and indels;
cMaximum number of encoded amino acids for each ORF;
dTotal number and percentage of variable amino acids based on the maximum number of amino acids derived from the established genome size for each HPV type;
eCG, complete genome. Each nucleotide position is counted once. A single genome size is inferred from the nucleotide alignment (indel was treated as one event).
NCR1, non-coding region 1 (between E2 and E5 ORFs); NCR2, non-coding region 2 (between E5 and L2 ORFs); URR, up stream regulatory region (between stop codon of
L1 and start codon of E6).
doi:10.1371/journal.pone.0020183.t002
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nomenclature will allow HPV researchers to discuss the properties
of HPV variant lineages without having to describe sets of
nucleotide changes to define a group of HPV variants. This will be
particularly useful for future studies of the alpha-9 species group of
HPVs that is an abundant and related group of viruses that have a
high pathogenic potential.
Papillomavirus genomes accumulate SNPs and indels (see
Figure S4) through a stochastic process based on mutation rates
similar to the host genomes they infect [59]. This reflects the fact
that PVs use the host’s DNA replication machinery to copy and
amplify their genomes; natural selection has likely played an
important role over the course of evolution to filter and fix
nucleotide changes within variant lineages. Whether the variation
Table 3. Calculation of HPV52, 58 and 67 variations by genome region and open reading frame (ORF).
Genome region
and ORF
Maximum nuc.
pairwise difference
Number of nucleotide
sequences
a
Number of variable
nuc. positions
b Number of
amino acids
c
Number of variable
aa positions
d
n% n %
HPV52 (n=23)
E6 2.2% 444 20 4.5% 147 5 3.4%
E7 3.3% 297 12 4.0% 98 7 7.1%
E1 1.7% 1941 64 3.3% 646 24 3.7%
E2 2.6% 1104 52 4.7% 367 29 7.9%
E4 3.4% 291 14 4.8% 96 8 8.3%
NCR1 8.4% 83 8 9.6%
E5 3.5% 225 11 4.9% 74 6 8.1%
NCR2 4.0% 129 8 6.2%
L2 1.9% 1398 47 3.4% 465 19 4.1%
L1 2.2% 1590 61 3.8% 529 15 2.8%
URR 3.9% 909 70 7.7%
CG
e 2.2% 7993 354 4.4% 2326 105 4.5%
HPV58 (n=37)
E6 1.8% 453 16 3.5% 150 8 5.3%
E7 3.4% 300 18 6.0% 99 12 12.1%
E1 1.3% 1938 74 3.8% 645 37 5.7%
E2 1.3% 1080 41 3.8% 359 23 6.4%
E4 2.2% 279 17 6.1% 92 14 15.2%
NCR1 3.2% 62 4 6.5%
E5 3.5% 234 15 6.4% 77 3 3.9%
NCR2 5.8% 122 14 11.5%
L2 2.4% 1422 80 5.6% 473 36 7.6%
L1 2.2% 1578 74 4.7% 525 29 5.5%
URR 3.2% 806 72 8.9%
CG
e 1.7% 7837 400 5.1% 2328 148 6.4%
HPV67 (n=8)
E6 1.3% 450 8 1.8% 149 3 2.0%
E7 1.7% 300 7 2.3% 99 4 4.0%
E1 1.3% 1911 30 1.6% 636 9 1.4%
E2 1.1% 1113 19 1.7% 370 10 2.7%
E4 1.7% 300 6 2.0% 99 4 4.0%
NCR1
E5 1.4% 222 3 1.4% 73 2 2.7%
NCR2 2.6% 117 6 5.1%
L2 0.9% 1398 18 1.3% 465 11 2.4%
L1 0.8% 1590 24 1.5% 529 6 1.1%
URR 1.8% 801 20 2.5%
CG
e 1.1% 7825 135 1.7% 2321 45 1.9%
a–e see footnotes for Table 2.
doi:10.1371/journal.pone.0020183.t003
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report) are determined by selection or genetic drift remain to be
determined. However, the relatively recent evolution of the alpha-
9 group of HPV types and variants cannot easily be explained by
natural selection. Analyses used to detect selection at individual
codon position [60] identified only a few scattered nucleotide sites
under Darwinian selection. This might be expected in viruses that
have existed for hundreds of millions of years [61], and have
perfected a survival strategy and optimized their structural
components via natural selection [61,62]. This inference is
supported by the existence of strong purifying selection and
conserved genome regions that are most evident in the L1, L2, E1
and E2 ORFs. Other regions of the genome have more flexibility
to adapt HPVs to different biological niches, but the exact
mechanisms and sequences responsible for these changes have not
been identified. Moreover, since recombination is not a major
form of papillomavirus evolution, SNPs are not correlated by
distance, as is observed in the human hapmap and 1000 genome
projects resulting in linkage disequilibrium (LD) blocks [63,64]. In
contrast, HPV evolution results in genome variation where
changes in one region of the genome are highly correlated with
those in other regions of variants from the same lineage (Figure 8).
Nevertheless, there is at least one example of recombination
between a polyomavirus and a papillomavirus [65] indicating that
recombination has occurred in the distant past and could occur in
the future. To date, our laboratory has not observed direct
evidence of recombination in human papillomavirus genomes, and
there is a lack of compelling data to suggest that recombination is
important in the evolution of the alpha-9 HPVs.
In summary, we present an extensive description of the HPV16-
related alpha-9 papillomavirus variants. We provide a taxonomy
and nomenclature of these variants that should be useful for
evolutionary biologists, virologists, epidemiologists and health care
workers. Nevertheless, the mechanisms of adaptation and
oncogenic pathogenicity of the alpha-9 HPVs will require
additional studies and their role in morbidity and mortality,
especially for cervix cancer, will continue for decades to come.
Supporting Information
Figure S1 Distribution of pairwise differences between
nucleotide sequences of HPV16-related alpha-9 type
genomes. The genome nucleotide sequences of each type were
globally aligned using the program MAFFT v6.846 [46]. The p-
distance method in the MEGA5 [54] was used to calculate the
percent differences for each isolate comparing to all other isolates
of the same type based on a global alignment. The Y-axis
represents the number of comparisons. The X-axis shows the
percent nucleotide pairwise differences. (A) Comparison of each
isolate to all other isolates of the same type, resulting in a total of
1686 values. (B) Inter- and intra-lineage pairwise differences. Inter-
lineage: comparisons of isolates within different lineages of the
same type (894 comparisons). Intra-lineage: comparisons of
isolates within the same lineage (790 comparisons). (C) Inter-
and intra-sublineage pairwise differences. Inter-sublineage: com-
parisons of isolates within different sublineages of the same lineage
(338 comparisons). Intra-sublineage: comparisons of isolates within
the same sublineage (452 comparisons).
(PDF)
Figure S2 Variation at nucleotide and amino acid
positions within the complete genomes and ORFs of
HPV16-related alpha-9 isolates. Amino acids alignments were
used to guide the nucleotide sequence alignments as previously
described [12]. The original Genbank sequence for each type is
used as the reference for all alignments and is shown at the top of
each panel. Only sites that are different are displayed. Below the
nucleotide sequence alignments are the corresponding amino acid
differences for each ORF. The nucleotide sequence variations are
shown for each position listed at the top of the panel by ORF or
region. Under the reference sequence the nucleotide sequence of
each isolate is displayed listing only sites that are different from the
reference sequence in one or more of the isolates (name is on the left
of the panel with the type|sample identifier|lineage or sublineage
listed). Dots, sites matched with reference sequence; dashes, indel
events. NCR1, noncoding region between E2 and E5 ORFs;
NCR2, noncoding region between E5 and L2 ORFs; URR,
upstream regulatory region located between stop codon of L1 and
start codon of E6. Genome sequences for each lineage or sublineage
are alternatively shown as grey blocks for visualization of most
closely related isolates. (A) alignment of HPV31 complete genomes,
(B) alignment of HPV33 complete genomes, (C) alignment of
HPV35 complete genomes, (D) alignment of HPV52 complete
genomes, (E) alignment of HPV58 complete genomes, and (F)
alignment of HPV67 complete genomes.
(PDF)
Figure S3 Early and late gene tree comparison. The trees
were constructed using the MrBayes (v3.1.2) program based on the
concatenated nucleotide sequences of ‘‘early genes’’ (E6, E7, E1,
E2 and E5) (Panel A) and ‘‘late genes’’ (L2 and L1) (Panel B). To
root the tree, HPV34 and HPV73 prototype sequences (NCBI
accession numbers X74476 and X94165) were set as the outgroup
and are represented by grey broken lines. The shaded areas
represent groupings of lineages and sublineages of HPV16,
HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. The
length of broken and solid lines represent distance between clades,
although the number of changes is different for these two lines, the
scale is indicated in the upper left corner of the figure.
(PDF)
Figure S4 Representation of an alpha-9 HPV genome
and ORF/region length ranges. Each region or ORF of the
HPV genome is indicated outside the double-stranded circle.
Lengths of each ORF and region are indicated by the histogram
pointing to the region/ORF in the figure. The length in nucleotide
sequences (bp) for each HPV16-related alpha-9 HPV genome is
indicated with the minimal and maximal lengths represented by
the bars with dots or highlighted in grey, respectively. The
diagram of the HPV genome is not drawn to scale and the
histogram for each ORF/region is presented in a different range of
values.
(PDF)
Table S1 List of HPV genomes by type, isolate name,
geographic origin of sample, lineage designation, length
of complete genome and NCBI #.
(PDF)
Table S2 Nucleotide sequence mean difference (±
standard error) of HPV16-related alpha-9 HPV complete
genomes. The intra-lineage (e.g., A vs. A) and intra-sublineage
(e.g., A1 vs. A1) difference values are highlighted in gray.
(PDF)
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